比较 epcoritamab 与化学免疫治疗的治疗结果 ,基于 polatuzumab 的方案 ,以塔法他单抗为基础的方案 ,或嵌合抗原受体 T 细胞疗法 ,在三线或后期复发 / 难治性大 B 细胞淋巴瘤中。
关键词: Diffuse large B-cell lymphoma Electronic health records Mortality Non-Hodgkin lymphoma Propensity score weighting Proportional-hazards models Retrospective studies
Mesh : Humans Lymphoma, Large B-Cell, Diffuse / drug therapy therapy Antibodies, Monoclonal, Humanized / therapeutic use administration & dosage Treatment Outcome Immunotherapy / methods Immunotherapy, Adoptive / methods Male Female Middle Aged Antineoplastic Combined Chemotherapy Protocols / therapeutic use Aged Adult Neoplasm Recurrence, Local / drug therapy
来 源:
DOI:10.1186/s13045-024-01594-x
PDF(Pubmed)